Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD - mixed treatment comparisons of clinical efficacy.

Saved in:
Bibliographic Details
Title: Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD - mixed treatment comparisons of clinical efficacy.
Authors: Stynes, Gillian1 gillian.x.stynes@gsk.com, Svedsater, Henrik1, Jaro Wex1, Lettis, Sally2, Leather, David3, Castelnuovo, Emanuela4, Detry, Michelle5, Berry, Scott5
Source: Respiratory Research. 2015, Vol. 16 Issue 2, p1-11. 11p. 1 Diagram, 2 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:14659921
DOI:10.1186/s12931-015-0184-8